May 18, 2015

MD op-ed: Overcoming roadblocks for imaging biomarker utilization in clinical cancer trials

With the dramatic increase in capabilities and importance of individualized cancer therapies targeting specific tumors according to molecular makeup, it would seem like a no-brainer to incorporate a wide-range of imaging biomarkers into clinical trials and, eventually, clinical practice. {read more here}